Brief: Intercept Pharmaceuticals Q2 Sales USD 83.7 Million Vs. IBES Estimate USD 79.6 Million
02/08/2023 12:00
Aug 02 (Reuters) - Intercept Pharmaceuticals Q2 operating expenses USD 84.5 million
Recent news on Intercept Pharmaceuticals
See all newsIntercept Pharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Digitalbridge Group, Huntington Ingalls Industries, Workday
U.S. RESEARCH ROUNDUP-Docusign, Immunovant, Liberty Energy
U.S. STOCKS ON THE MOVE-Amazon, United Parcel Service, Nike
U.S. STOCKS ON THE MOVE-BullFrog AI, Soleno,